Search

Your search keyword '"Suryapranata, H."' showing total 970 results

Search Constraints

Start Over You searched for: Author "Suryapranata, H." Remove constraint Author: "Suryapranata, H." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
970 results on '"Suryapranata, H."'

Search Results

4. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.

5. Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

6. Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

7. Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor

10. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

15. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

16. Versatile Aspects of Cardiac Troponin Assessment: Innovative Clinical Settings, Coronary Sinus Sampling, and Qualitative Laboratory Analyses

17. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

18. Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients:long-term results of a randomised trial

20. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

21. Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

22. Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial

25. Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury

26. Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention

27. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials

30. Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients

37. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

40. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention : a prespecified sub-analysis of the GLOBAL LEADERS trial

41. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry

42. Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort

44. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor

45. Proof of principle of a novel co-pulsating intra-ventricular membrane pump

46. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials

47. Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues

48. Effects of chronic beta-blocker treatment on admission haemodynamics in STEMI patients treated with primary angioplasty

50. Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention

Catalog

Books, media, physical & digital resources